Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Neuroplasticity01:01

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural products modulate social behavior and gut microbiota in a valproic acid-induced zebrafish model of autism spectrum disorder.

Biomolecules & biomedicine·2026
Same author

Interferon-β Deficiency Selectively Modulates Chronic Microglial Pathways after Traumatic Brain Injury.

Journal of neurotrauma·2026
Same author

Obesity-Induced PVAT Dysfunction and Atherosclerosis Development: The Role of GHSR-1a in Increased Macrophage Infiltration and Adipocytokine Secretion.

Journal of cardiovascular development and disease·2025
Same author

Molecular Pathway Changes Associated with Different Post-Conditioning Exercise Interventions After Experimental TBI.

Journal of neurotrauma·2024
Same author

Spinal cord injury disrupts plasma extracellular vesicles cargoes leading to neuroinflammation in the brain and neurological dysfunction in aged male mice.

Brain, behavior, and immunity·2024
Same author

Old age alters inflammation and autophagy signaling in the brain, leading to exacerbated neurological outcomes after spinal cord injury in male mice.

Brain, behavior, and immunity·2024

Related Experiment Video

Updated: Jul 14, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

Neuroprotection: challenges and opportunities.

Alan I Faden1, Bogdan Stoica

  • 1Department of Neuroscience, Georgetown University Medical Center, Washington, DC 20057, USA. fadena@georgetown.edu

Archives of Neurology
|June 15, 2007
PubMed
Summary

Neuroprotective drugs show promise in animal models but have failed in human trials for stroke and head injuries. This review examines challenges and potential solutions for future clinical success.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Pharmacological agents effectively limit secondary damage in animal models of central nervous system injury.
  • Translating neuroprotective strategies from animal models to human clinical trials for stroke, head injury, and spinal cord injury has yielded disappointing results.
  • Numerous conceptual and methodological issues hinder the clinical translation of experimental neuroprotection.

Purpose of the Study:

  • To review critical problems and potential solutions in translating neuroprotective treatments for central nervous system injuries.
  • To emphasize recent experimental and clinical work in neuroprotection.
  • To provide cautious optimism for future clinical trials of neuroprotective agents.

Main Methods:

  • Literature review of experimental and clinical studies on neuroprotection.

More Related Videos

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

Related Experiment Videos

Last Updated: Jul 14, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

  • Analysis of conceptual and methodological challenges in clinical translation.
  • Emphasis on recent advancements in experimental approaches and clinical trial design.

    • Main Results:

    • Despite established efficacy in animal models, neuroprotective agents have largely failed in human trials for neurological injuries.
    • Key challenges include differences in injury models, treatment timing, and clinical trial methodologies.
    • Recent modifications in experimental and clinical approaches offer renewed hope for neuroprotection.

    Conclusions:

    • Translating neuroprotective therapies for central nervous system injuries remains a significant challenge.
    • Addressing methodological and conceptual issues is crucial for successful clinical translation.
    • Continued research and innovative trial designs may lead to effective neuroprotective treatments in the future.